MRNA vs. MRNY
MRNA (Moderna, Inc.) is a stock, while MRNY (YieldMax MRNA Option Income Strategy ETF) is Derivative Income fund actively managed by YieldMax. Over the past year, MRNA returned 104.79% vs 65.32% for MRNY. Their 0.97 correlation means they have historically moved very closely together.
Performance
MRNA vs. MRNY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MRNA achieves a 90.76% return, which is significantly higher than MRNY's 66.15% return.
MRNA
- 1D
- -1.29%
- 1M
- -31.23%
- 6M
- 31.53%
- YTD
- 90.76%
- 1Y
- 104.79%
- 3Y*
- -19.59%
- 5Y*
- -32.90%
- 10Y*
- —
- ALL TIME*
- 13.04%
MRNY
- 1D
- -0.80%
- 1M
- -24.99%
- 6M
- 21.85%
- YTD
- 66.15%
- 1Y
- 65.32%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -21.29%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
MRNA Moderna, Inc. | $282.14M | $344.16M | $450.25M |
| $2.11M | $3.29M | $3.14M |
MRNA vs. MRNY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
MRNA Moderna, Inc. | 90.76% | -29.08% | -58.19% | 26.46% |
MRNY YieldMax MRNA Option Income Strategy ETF | 66.15% | -35.72% | -59.32% | 18.27% |
Correlation
The correlation between MRNA and MRNY is 0.98 - they have historically moved very closely together. At this level, their price movements offset little of one another.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.98 |
Correlation (All Time) Calculated using the full available price history since Oct 24, 2023 | 0.97 |
The correlation between MRNA and MRNY has been stable across timeframes, ranging from 0.97 to 0.98 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRNA vs. MRNY — Risk / Return Rank
MRNA
MRNY
MRNA vs. MRNY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Moderna, Inc. (MRNA) and YieldMax MRNA Option Income Strategy ETF (MRNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MRNA | MRNY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.29 | ||
| Sortino ratioReturn per unit of downside risk | +0.35 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.24 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 3.11 | 2.28 | +0.83 |
| Martin ratioReturn relative to average drawdown | 8.01 | 6.46 | +1.55 |
Loading charts...
Drawdowns
MRNA vs. MRNY - Drawdown Comparison
The maximum MRNA drawdown since its inception was -95.38%, which is greater than MRNY's maximum drawdown of -82.15%. Use the drawdown chart below to compare losses from any high point for MRNA and MRNY.
Loading charts...
Drawdown Indicators
| MRNA | MRNY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.38% | -82.15% | -13.23% |
Max Drawdown (1Y)Largest decline over 1 year | -33.90% | -28.84% | -5.06% |
Max Drawdown (3Y)Largest decline over 3 years | -86.58% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -95.38% | — | — |
Current DrawdownCurrent decline from peak | -88.39% | -65.02% | -23.37% |
Average DrawdownAverage peak-to-trough decline | -57.62% | -53.23% | -4.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.15% | 10.16% | +2.99% |
Volatility
MRNA vs. MRNY - Volatility Comparison
Moderna, Inc. (MRNA) has a higher volatility of 19.61% compared to YieldMax MRNA Option Income Strategy ETF (MRNY) at 15.82%. This indicates that MRNA's price experiences larger fluctuations and is considered to be riskier than MRNY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MRNA | MRNY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.61% | 15.82% | +3.79% |
Volatility (6M)Calculated over the trailing 6-month period | 47.84% | 36.22% | +11.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.65% | 52.68% | +15.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.73% | 51.47% | +15.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 72.34% | 51.47% | +20.87% |
Dividends
MRNA vs. MRNY - Dividend Comparison
MRNA has not paid dividends to shareholders, while MRNY's dividend yield for the trailing twelve months is around 98.29%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
MRNY YieldMax MRNA Option Income Strategy ETF | 98.29% | 145.98% | 178.49% | 1.75% |
Frequently Asked Questions
With a correlation of 0.98, MRNA and MRNY move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
MRNA has higher volatility (19.61%) compared to MRNY (15.82%). In terms of maximum drawdown, MRNA dropped -95.38% vs MRNY's -82.15%.
MRNA currently has the higher Sharpe Ratio (1.54 vs 1.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MRNA and MRNY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer